查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1948345

2026年全球组织微阵列市场报告

Tissue Microarray Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，组织晶片市场规模快速成长，预计将从2025年的131.1亿美元成长到2026年的146.8亿美元，复合年增长率达12.0%。过去几年的成长可归因于癌症研究活动的拓展、免疫组织化学技术的日益普及、学术病理学研究的扩展、对生物标记检验工具需求的增加以及石蜡包埋组织样本的可获得性。

预计未来几年组织晶片市场将快速成长，到2030年市场规模将达到236.1亿美元，复合年增长率（CAGR）为12.6%。预测期内的成长要素包括：精准肿瘤学研究投资的增加、数位病理解决方案的日益普及、转化研究的进展、对多组体学分析需求的增长以及组织晶片在药物研发中应用的不断广泛。预测期内的关键趋势包括：高通量组织分析平台的广泛应用、多重免疫组化技术的日益普及、对标准化组织晶片的需求不断增长、自动化组织晶片构建技术的日益普及以及与分子诊断领域合作的加强。

未来几年，对个人化医疗日益增长的需求预计将推动组织晶片市场的成长。个人化医疗根据患者的个别特征客製化治疗方案，提供更精准有效的照护。组织晶片在个人化医疗中用于同时分析多个组织样本，从而实现快速高效的生物标记评估，为个人化治疗提供依据。例如，根据美国非营利组织个人化医疗联盟（Personalized Medicine Coalition）2024年2月发布的消息，美国食品药物管理局（FDA）在2023年核准了16种针对罕见疾病患者的新型个人化疗法，较2022年核准的6种显着增加。这种对个人化医疗日益增长的需求正在推动组织晶片市场的成长。

组织晶片市场的主要企业正专注于微阵列平台等先进解决方案，以提高高通量组织分析的准确性和效率。微阵列平台是一种能够在小面积表面上同时分析多个基因和其他生物分子的技术，从而促进基因和表现研究。例如，2023年6月，西班牙海洋医院（Hospital del Mar）的医学研究机构MARGenomics推出了Applied Biosystems GeneChip 3000 Dx v2，这是一款由卡洛斯三世健康研究所（ISCIII）和欧盟「下一代欧盟」（Next Generation EU）倡议资助的先进微阵列平台。该系统是欧洲和美国首个获得诊断用途监管核准的微阵列平台，并已获得体外诊断医疗设备（IVD-R）认证。它提供多种功能，包括基因组和表达微阵列。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球组织晶片市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 数位化、云端运算、巨量资料、网路安全
    • 工业4.0和智慧製造
    • 人工智慧与自主智能
    • 物联网 (IoT)、智慧基础设施和互联生态系统
  • 主要趋势
    • 高通量组织分析平台的使用日益增多
    • 多重免疫组织化学技术的应用日益广泛
    • 对标准化组织晶片的需求日益增长
    • 扩展自动化组织微阵列构建
    • 加强与分子诊断领域的合作

第五章 终端用户产业市场分析

  • 製药和生物技术公司
  • 研究所
  • 医院
  • 学术研究机构
  • 诊断检查室

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球组织微阵列市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 全球组织晶片市场规模、对比及成长率分析
  • 全球组织微阵列市场表现：规模与成长，2020-2025年
  • 全球组织晶片市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场总量（TAM）

第九章 市场细分

  • 按类型
  • 免疫组织化学、萤光杂合反应、冷冻组织晶片和其他类型
  • 透过技术
  • 基于免疫组织化学（IHC）的检测、原位杂合反应（ISH）技术、数位病理学和影像分析、组织晶片建构技术、讯号检测和视觉化技术
  • 透过使用
  • 肿瘤学研究和生物标记检验、药物发现和开发、转化和临床研究、蛋白质表达和定位分析、基因和RNA表达分析（基于组织）、比较病理学和毒理学研究
  • 最终用户
  • 製药和生物技术公司、研究机构、医院
  • 按类型细分：免疫组织化学
  • 自动化免疫组织化学、手工免疫组织化学、多重免疫组织化学
  • 依类型进行亚分割：萤光杂合反应（FISH）
  • 单色鱼、多色鱼、DNA鱼
  • 按类型细分：冷冻组织晶片
  • 冷冻组织微阵列、速冻组织阵列
  • 按类型细分：其他类型
  • RNA原位杂合反应，石蜡包埋组织晶片

第十章 区域与国家分析

  • 全球组织晶片市场：区域分析、预测（2020-2025年、2025-2030年预测、2035年预测）
  • 全球组织晶片市场：国家、效能与预测，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 组织微阵列市场：竞争格局及市场占有率（2024年）
  • 组织微阵列市场：公司估值矩阵
  • 组织晶片市场：公司概况
    • BioIVT LLC
    • BioChain Institute Inc.
    • Creative Bioarray Co.
    • 3DHISTECH Ltd.
    • OriGene Technologies Inc.

第37章：其他领先和创新企业

  • Bio SB Inc., ProteoGenex Inc., US Biomax Inc., AMS Biotechnology Ltd., TissueArray.Com LLC, Pantomics Inc., Zyagen Inc., Asterand Bioscience, Indivumed GmbH, PrecisionMed Inc., Conversant Bio AB, RayBiotech Life Inc., Novus Biologicals LLC, Tristar Group, iSpecimen Inc.

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年组织微阵列市场：提供新机会的国家
  • 2030年组织微阵列市场：新兴细分市场机会
  • 组织微阵列市场展望（2030 年）：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME4MTMIC01_G26Q1

A tissue microarray is a high-throughput technology that enables comprehensive analysis of antigen expression across numerous tissues and cells in a single experiment, typically using paraffin blocks or formalin. It allows for the simultaneous assessment of protein expression in multiple tissue samples.

The primary types of tissue microarrays include immunohistochemistry, fluorescent in situ hybridization, frozen tissue array, and other variants. Immunohistochemistry (IHC) is a technique used to diagnose certain types of cancer, such as mesothelioma, by employing a visual marker to locate antigens in biopsy tissue. Various technologies such as DNA microarrays, polymerase chain reaction (PCR), next-generation sequencing, northern blotting, western blotting, and others are utilized for applications in oncology, gene expression profiling, single nucleotide polymorphism (SNP) detection, double-stranded B-DNA microarrays, comparative genomic hybridization, sequencing bioinformatics, and more. These technologies find applications across different end-users, including pharmaceutical and biotechnological companies, research organizations, and hospitals.

Tariffs are influencing the tissue microarray market by increasing costs of imported laboratory instruments, microarray construction systems, reagents, and imaging equipment. Research institutions and pharmaceutical companies in North America and Europe are most affected due to dependence on imported precision tools, while Asia-Pacific faces higher costs for advanced research infrastructure. These tariffs are raising operational expenses and slowing laboratory upgrades. At the same time, they are supporting domestic production of laboratory equipment and fostering regional research supply chains.

The tissue microarray market research report is one of a series of new reports from The Business Research Company that provides tissue microarray market statistics, including tissue microarray industry global market size, regional shares, competitors with a tissue microarray market share, detailed tissue microarray market segments, market trends and opportunities, and any further data you may need to thrive in the tissue microarray industry. This tissue microarray market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The tissue microarray market size has grown rapidly in recent years. It will grow from $13.11 billion in 2025 to $14.68 billion in 2026 at a compound annual growth rate (CAGR) of 12.0%. The growth in the historic period can be attributed to growing cancer research activities, increasing adoption of immunohistochemistry techniques, expansion of academic pathology research, rising demand for biomarker validation tools, availability of paraffin-embedded tissue samples.

The tissue microarray market size is expected to see rapid growth in the next few years. It will grow to $23.61 billion in 2030 at a compound annual growth rate (CAGR) of 12.6%. The growth in the forecast period can be attributed to increasing investments in precision oncology research, rising adoption of digital pathology solutions, expansion of translational research initiatives, growing demand for multi-omics analysis, increasing use of tissue microarrays in drug discovery. Major trends in the forecast period include increasing use of high-throughput tissue analysis platforms, rising adoption of multiplex immunohistochemistry, growing demand for standardized tissue arrays, expansion of automated tissue microarray construction, enhanced integration with molecular diagnostics.

The growing demand for personalized medicine is expected to drive growth in the tissue microarray market in the coming years. Personalized medicine customizes medical treatment based on individual patient characteristics to deliver more precise and effective care. Tissue microarrays are used in personalized medicine to analyze multiple tissue samples simultaneously, enabling rapid and efficient biomarker assessment for tailored patient treatments. For example, in February 2024, the Personalized Medicine Coalition, a US-based nonprofit organization, reported that the US FDA approved 16 new personalized treatments for rare disease patients in 2023, up significantly from six approvals in 2022. Thus, the growing demand for personalized medicine is fueling growth in the tissue microarray market.

Major companies operating in the tissue microarray market are focusing on advanced solutions, such as microarray platforms to enhance precision and efficiency in high-throughput tissue analysis. A microarray platform is a technology that allows for simultaneous analysis of multiple genes or other biomolecules on a small surface, facilitating genetic and expression studies. For instance, in June 2023, MARGenomics, a Spain-based hospital del Mar medical research institute, launched the Applied Biosystems GeneChip 3000 Dx v2, an advanced microarray platform funded by the Carlos III Health Institute (ISCIII) and the European Union's NextGenerationEU initiative. It is the inaugural microarray platform in both Europe and the United States to receive regulatory approval for diagnostic purposes, attaining IVD-R (In Vitro Diagnosis Regulation) certification. The system boasts diverse functionalities, encompassing genomic and expression microarrays.

In May 2024, Bruker Corporation, a US-based provider of high-performance scientific instruments and analytical solutions, acquired NanoString Technologies for approximately USD 392.6 million. Through this acquisition, Bruker aims to expand its spatial biology and transcriptomics capabilities, strengthen its position in high-plex tissue analysis, and enhance its technology portfolio for advanced tissue-based and translational research workflows. NanoString Technologies, also US-based, provides spatial transcriptomics, single-cell imaging, and gene-expression analysis platforms widely used in whole-tissue and tissue-microarray research applications.

Major companies operating in the tissue microarray market are BioIVT LLC, BioChain Institute Inc., Creative Bioarray Co., 3DHISTECH Ltd., OriGene Technologies Inc., Bio SB Inc., ProteoGenex Inc., US Biomax Inc., AMS Biotechnology Ltd., TissueArray.Com LLC, Pantomics Inc., Zyagen Inc., Asterand Bioscience, Indivumed GmbH, PrecisionMed Inc., Conversant Bio AB, RayBiotech Life Inc., Novus Biologicals LLC, Tristar Group, iSpecimen Inc.

North America was the largest region in the tissue microarray market in 2025. Asia-Pacific is expected to be the fastest-growing region in the tissue microarray market report during the forecast period. The regions covered in the tissue microarray market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the tissue microarray market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The tissue microarray market consists of sales of molds, needles, and tissue punches. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tissue Microarray Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses tissue microarray market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tissue microarray ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The tissue microarray market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Immunohistochemistry; Fluorescent In Situ Hybridization; Frozen Tissue Array; Other Types
  • 2) By Technology: Immunohistochemistry (IHC)-Based Detection; In Situ Hybridization (ISH) Technologies; Digital Pathology and Image Analysis; Tissue Microarray Construction Technologies; Signal Detection and Visualization Technologies
  • 3) By Application: Oncology Research and Biomarker Validation; Drug Discovery and Development; Translational and Clinical Research; Protein Expression and Localization Analysis; Gene and RNA Expression Analysis (Tissue-Based); Comparative Pathology and Toxicology Studies
  • 4) By End-User: Pharmaceutical And Biotechnological Companies; Research Organizations; Hospitals
  • Subsegments:
  • 1) By Immunohistochemistry: Automated Immunohistochemistry; Manual Immunohistochemistry; Multiplex Immunohistochemistry
  • 2) By Fluorescent In Situ Hybridization (FISH): Single-Color FISH; Multi-Color FISH; DNA FISH
  • 3) By Frozen Tissue Array: Tissue Microarray from Frozen Samples; Snap-Frozen Tissue Array
  • 4) By Other Types: RNA In Situ Hybridization; Paraffin-Embedded Tissue Array
  • Companies Mentioned: BioIVT LLC; BioChain Institute Inc.; Creative Bioarray Co.; 3DHISTECH Ltd.; OriGene Technologies Inc.; Bio SB Inc.; ProteoGenex Inc.; US Biomax Inc.; AMS Biotechnology Ltd.; TissueArray.Com LLC; Pantomics Inc.; Zyagen Inc.; Asterand Bioscience; Indivumed GmbH; PrecisionMed Inc.; Conversant Bio AB; RayBiotech Life Inc.; Novus Biologicals LLC; Tristar Group; iSpecimen Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Tissue Microarray Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Tissue Microarray Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Tissue Microarray Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Tissue Microarray Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics And Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data And Cybersecurity
    • 4.1.3 Industry 4.0 And Intelligent Manufacturing
    • 4.1.4 Artificial Intelligence And Autonomous Intelligence
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure And Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Increasing Use Of High-Throughput Tissue Analysis Platforms
    • 4.2.2 Rising Adoption Of Multiplex Immunohistochemistry
    • 4.2.3 Growing Demand For Standardized Tissue Arrays
    • 4.2.4 Expansion Of Automated Tissue Microarray Construction
    • 4.2.5 Enhanced Integration With Molecular Diagnostics

5. Tissue Microarray Market Analysis Of End Use Industries

  • 5.1 Pharmaceutical And Biotechnological Companies
  • 5.2 Research Organizations
  • 5.3 Hospitals
  • 5.4 Academic Research Institutes
  • 5.5 Diagnostic Laboratories

6. Tissue Microarray Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Tissue Microarray Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Tissue Microarray PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Tissue Microarray Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Tissue Microarray Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Tissue Microarray Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Tissue Microarray Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Tissue Microarray Market Segmentation

  • 9.1. Global Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Immunohistochemistry, Fluorescent In Situ Hybridization, Frozen Tissue Array, Other Types
  • 9.2. Global Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Immunohistochemistry (IHC)-Based Detection, In Situ Hybridization (ISH) Technologies, Digital Pathology and Image Analysis, Tissue Microarray Construction Technologies, Signal Detection and Visualization Technologies
  • 9.3. Global Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Oncology Research and Biomarker Validation, Drug Discovery and Development, Translational and Clinical Research, Protein Expression and Localization Analysis, Gene and RNA Expression Analysis (Tissue-Based), Comparative Pathology and Toxicology Studies
  • 9.4. Global Tissue Microarray Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Pharmaceutical And Biotechnological Companies, Research Organizations, Hospitals
  • 9.5. Global Tissue Microarray Market, Sub-Segmentation Of Immunohistochemistry, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Automated Immunohistochemistry, Manual Immunohistochemistry, Multiplex Immunohistochemistry
  • 9.6. Global Tissue Microarray Market, Sub-Segmentation Of Fluorescent In Situ Hybridization (FISH), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Single-Color FISH, Multi-Color FISH, DNA FISH
  • 9.7. Global Tissue Microarray Market, Sub-Segmentation Of Frozen Tissue Array, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Tissue Microarray from Frozen Samples, Snap-Frozen Tissue Array
  • 9.8. Global Tissue Microarray Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • RNA In Situ Hybridization, Paraffin-Embedded Tissue Array

10. Tissue Microarray Market Regional And Country Analysis

  • 10.1. Global Tissue Microarray Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Tissue Microarray Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Tissue Microarray Market

  • 11.1. Asia-Pacific Tissue Microarray Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Tissue Microarray Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Tissue Microarray Market

  • 12.1. China Tissue Microarray Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Tissue Microarray Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Tissue Microarray Market

  • 13.1. India Tissue Microarray Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Tissue Microarray Market

  • 14.1. Japan Tissue Microarray Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Tissue Microarray Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Tissue Microarray Market

  • 15.1. Australia Tissue Microarray Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Tissue Microarray Market

  • 16.1. Indonesia Tissue Microarray Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Tissue Microarray Market

  • 17.1. South Korea Tissue Microarray Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Tissue Microarray Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Tissue Microarray Market

  • 18.1. Taiwan Tissue Microarray Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Tissue Microarray Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Tissue Microarray Market

  • 19.1. South East Asia Tissue Microarray Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Tissue Microarray Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Tissue Microarray Market

  • 20.1. Western Europe Tissue Microarray Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Tissue Microarray Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Tissue Microarray Market

  • 21.1. UK Tissue Microarray Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Tissue Microarray Market

  • 22.1. Germany Tissue Microarray Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Tissue Microarray Market

  • 23.1. France Tissue Microarray Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Tissue Microarray Market

  • 24.1. Italy Tissue Microarray Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Tissue Microarray Market

  • 25.1. Spain Tissue Microarray Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Tissue Microarray Market

  • 26.1. Eastern Europe Tissue Microarray Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Tissue Microarray Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Tissue Microarray Market

  • 27.1. Russia Tissue Microarray Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Tissue Microarray Market

  • 28.1. North America Tissue Microarray Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Tissue Microarray Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Tissue Microarray Market

  • 29.1. USA Tissue Microarray Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Tissue Microarray Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Tissue Microarray Market

  • 30.1. Canada Tissue Microarray Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Tissue Microarray Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Tissue Microarray Market

  • 31.1. South America Tissue Microarray Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Tissue Microarray Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Tissue Microarray Market

  • 32.1. Brazil Tissue Microarray Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Tissue Microarray Market

  • 33.1. Middle East Tissue Microarray Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Tissue Microarray Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Tissue Microarray Market

  • 34.1. Africa Tissue Microarray Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Tissue Microarray Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Tissue Microarray Market Regulatory and Investment Landscape

36. Tissue Microarray Market Competitive Landscape And Company Profiles

  • 36.1. Tissue Microarray Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Tissue Microarray Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Tissue Microarray Market Company Profiles
    • 36.3.1. BioIVT LLC Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. BioChain Institute Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Creative Bioarray Co. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. 3DHISTECH Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. OriGene Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Tissue Microarray Market Other Major And Innovative Companies

  • Bio SB Inc., ProteoGenex Inc., US Biomax Inc., AMS Biotechnology Ltd., TissueArray.Com LLC, Pantomics Inc., Zyagen Inc., Asterand Bioscience, Indivumed GmbH, PrecisionMed Inc., Conversant Bio AB, RayBiotech Life Inc., Novus Biologicals LLC, Tristar Group, iSpecimen Inc.

38. Global Tissue Microarray Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Tissue Microarray Market

40. Tissue Microarray Market High Potential Countries, Segments and Strategies

  • 40.1 Tissue Microarray Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Tissue Microarray Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Tissue Microarray Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer